Xinmin Liu Selected Research

protopanaxadiol

1/2020	Ginsenoside 20(S)-protopanaxadiol attenuates depressive-like behaviour and neuroinflammation in chronic unpredictable mild stress-induced depressive rats.
1/2019	Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
1/2018	20(S)-protopanaxadiol (PPD) alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of Egr-1, c-Fos and c-Jun in mice.
1/2018	The protective effect of 20(S)-protopanaxadiol (PPD) against chronic sleep deprivation (CSD)-induced memory impairments in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinmin Liu Research Topics

Disease

19	Neoplasms (Cancer) 12/2021 - 06/2005
13	Cognitive Dysfunction 03/2022 - 07/2009
9	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 04/2012
8	Neuroinflammatory Diseases 05/2022 - 01/2020
7	Inflammation (Inflammations) 05/2022 - 10/2019
7	Dementia (Dementias) 11/2020 - 11/2011
6	Lung Neoplasms (Lung Cancer) 01/2020 - 06/2005
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2013
5	Sleep Deprivation 05/2022 - 05/2017
5	Memory Disorders (Memory Loss) 01/2021 - 10/2007
5	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020 - 11/2011
4	Hypoxia (Hypoxemia) 01/2021 - 04/2017
4	Fibrosis (Cirrhosis) 01/2020 - 07/2009
4	Infections 01/2019 - 01/2013
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2018 - 07/2009
4	Fatigue 03/2018 - 10/2015
3	Insulin Resistance 01/2022 - 11/2020
3	COVID-19 01/2021 - 01/2020
3	Stroke (Strokes) 01/2021 - 08/2013
3	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2019
3	Amnesia (Dissociative Amnesia) 06/2018 - 01/2018
3	Neuroblastoma 12/2017 - 09/2010
3	Schizophrenia (Dementia Praecox) 04/2012 - 07/2004
2	Nausea 01/2022 - 01/2022
2	Vomiting 01/2022 - 01/2022
2	Hypertension (High Blood Pressure) 01/2022 - 11/2009
2	Postoperative Nausea and Vomiting (PONV) 01/2022 - 01/2022
2	Adenocarcinoma of Lung 12/2021 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2021 - 06/2017
2	Obesity 10/2021 - 07/2021
2	Glioma (Gliomas) 08/2021 - 01/2018
2	Atherosclerosis 01/2021 - 11/2020
2	Chronic Disease (Chronic Diseases) 11/2020 - 04/2012
2	Vascular Remodeling 01/2020 - 05/2018
2	Ischemia 01/2017 - 06/2008
2	Body Weight (Weight, Body) 05/2012 - 10/2007
1	Gout 01/2022

Drug/Important Bio-Agent (IBA)

8	AntioxidantsIBA 05/2022 - 10/2015
7	Proteins (Proteins, Gene)FDA Link 08/2021 - 11/2009
7	Scopolamine (Hyoscine)FDA Link 01/2021 - 10/2007
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 04/2012
5	Tuberculin (PPD)IBA 01/2020 - 09/2011
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 07/2009
5	Pharmaceutical PreparationsIBA 10/2019 - 03/2017
4	Neuroprotective AgentsIBA 05/2022 - 06/2018
4	IsoflavonesIBA 05/2022 - 06/2018
4	Neurotransmitter Agents (Neurotransmitter)IBA 07/2021 - 01/2020
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 01/2018
4	FlavonoidsIBA 11/2020 - 11/2011
4	GinsenosidesIBA 01/2020 - 09/2011
4	protopanaxadiolIBA 01/2020 - 01/2018
3	Antidepressive Agents (Antidepressants)IBA 07/2021 - 01/2020
3	Cholinergic Agents (Cholinergics)IBA 01/2021 - 01/2018
3	CytokinesIBA 01/2021 - 10/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 04/2012
3	CollagenIBA 01/2020 - 05/2018
3	Cadherins (E-Cadherin)IBA 01/2020 - 12/2018
3	Fibronectins (Fibronectin)IBA 01/2020 - 05/2018
3	Small Interfering RNA (siRNA)IBA 01/2020 - 06/2017
3	Phosphotransferases (Kinase)IBA 01/2019 - 01/2014
3	Biological ProductsIBA 01/2018 - 06/2005
2	NF-kappa B (NF-kB)IBA 03/2022 - 01/2020
2	HDL CholesterolIBA 01/2022 - 01/2021
2	Sirtuin 1IBA 01/2022 - 01/2020
2	Uric Acid (Urate)IBA 01/2022 - 01/2020
2	Dexmedetomidine FDA Link 01/2022 - 01/2022
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 08/2021 - 10/2019
2	LipopolysaccharidesIBA 07/2021 - 02/2020
2	Sucrose (Saccharose)IBA 01/2021 - 01/2021
2	ginsenoside Rh2IBA 01/2021 - 01/2018
2	InterleukinsIBA 01/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2019
2	PhytochemicalsIBA 11/2020 - 06/2018
2	Anti-Allergic Agents (Antiallergic Agents)IBA 11/2020 - 01/2018
2	fibrin fragment D (D-dimer)IBA 11/2020 - 01/2020
2	GenisteinIBA 04/2020 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 10/2019
2	solanesolIBA 01/2019 - 03/2017
2	indium-bleomycinIBA 12/2018 - 11/2017
2	PolyphenolsIBA 03/2018 - 10/2015
2	Kai-Xin-SanIBA 04/2017 - 07/2009
2	Amyloid beta-PeptidesIBA 04/2017 - 11/2012
2	gamma-Aminobutyric Acid (GABA)IBA 01/2017 - 01/2016
2	lavender oilIBA 01/2017 - 12/2016
2	LuteolinIBA 11/2011 - 09/2010
2	Caspase 3 (Caspase-3)IBA 01/2010 - 01/2009
2	Cystathionine gamma-Lyase (Cysteine Desulfhydrase)IBA 07/2009 - 06/2008
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2009 - 06/2008
1	tenuifolin diterpeneIBA 03/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2022
1	CorticosteroneIBA 03/2022
1	Toll-Like Receptor 4IBA 03/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	DiureticsIBA 01/2022

Therapy/Procedure

5	Therapeutics 01/2020 - 01/2011
2	Immunotherapy 12/2021 - 05/2018
2	Radiotherapy 05/2020 - 01/2019
1	Analgesia 01/2022
1	Operative Surgical Procedures 01/2022